0001209191-15-057569.txt : 20150630
0001209191-15-057569.hdr.sgml : 20150630
20150630161927
ACCESSION NUMBER: 0001209191-15-057569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150626
FILED AS OF DATE: 20150630
DATE AS OF CHANGE: 20150630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerulean Pharma Inc.
CENTRAL INDEX KEY: 0001401914
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 5TH FLOOR
CITY: Cambridge
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-551-9600
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 5TH FLOOR
CITY: Cambridge
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parkinson David Ross
CENTRAL INDEX KEY: 0001451935
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36395
FILM NUMBER: 15961641
MAIL ADDRESS:
STREET 1: C/O THRESHOLD PHARMACEUTICALS, INC.
STREET 2: 170 HARBOR WAY SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-26
0
0001401914
Cerulean Pharma Inc.
CERU
0001451935
Parkinson David Ross
C/O CERULEAN PHARMA INC.
840 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (Right to Buy)
4.78
2015-06-26
4
A
0
7000
0.00
A
2025-06-25
Common Stock
7000
7000
D
Stock Option (Right to Buy)
4.78
2015-06-26
4
A
0
11000
0.00
A
2025-06-25
Common Stock
11000
11000
D
This option was granted June 26, 2015. The shares underlying this option vest in three equal annual installments on October 29, 2015, October 29, 2016 and October 29, 2017, respectively.
This option was granted on June 26, 2015. The shares vest in full on the earlier of June 26, 2016 or immediately prior to the Corporation's 2016 annual meeting of stockholders, subject to Dr. Parkinson's continued service as a director of the Corporation through such date.
/s/ Alejandra Carvajal, as attorney-in-fact for David R. Parkinson
2015-06-30
EX-24.4_592522
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY
FOR SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned hereby makes, constitutes and
appoints each of Ronan O'Brien and Alejandra Carvajal, signing singly and each
acting individually, as the undersigned's true and lawful attorney in fact with
full power and authority as hereinafter described to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director and/or stockholder of Cerulean Pharma Inc. (the
"Company"), Forms 3, 4, and 5 (including any amendments thereto) in accordance
with Section 16(a) of the Securities Exchange Act of 1934 and the rules
thereunder (the "Exchange Act");
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to prepare, complete and execute any such Form 3,
4, or 5, prepare, complete and execute any amendment or amendments thereto, and
timely deliver and file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority;
(3) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information regarding transactions in the Company's securities from any
third party, including brokers, employee benefit plan administrators and
trustees, and the undersigned hereby authorizes any such person to release any
such information to such attorney in fact and approves and ratifies any such
release of information; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney in fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney in fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney in fact may approve in such
attorney in fact's discretion.
The undersigned hereby grants to each such attorney in fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney in fact, or such attorney
in fact's substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys in fact, in serving in
such capacity at the request of the undersigned, are not assuming nor relieving,
nor is the Company assuming nor relieving, any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act. The undersigned
acknowledges that neither the Company nor the foregoing attorneys in fact assume
(i) any liability for the undersigned's responsibility to comply with the
requirement of the Exchange Act, (ii) any liability of the undersigned for any
failure to comply with such requirements, or (iii) any obligation or liability
of the undersigned for profit disgorgement under Section 16(b) of the Exchange
Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys in fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 26th day of June, 2015.
Signature
/s/ David R. Parkinson
David R. Parkinson
Print Name